Patents by Inventor Lindsey Jane Hudson

Lindsey Jane Hudson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
    Publication number: 20210079114
    Abstract: The present invention provides methods and compositions for treatment, screening, diagnosis and prognosis of cancer, such as lung cancer, pancreatic cancer and skin cancer, for monitoring the effectiveness of cancer, such as lung cancer, pancreatic cancer and skin cancer treatment, and for drug development.
    Type: Application
    Filed: November 20, 2020
    Publication date: March 18, 2021
    Inventor: Lindsey Jane HUDSON
  • THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
    Publication number: 20180201691
    Abstract: The present invention provides methods and compositions for treatment, screening, diagnosis and prognosis of cancer, such as lung cancer, pancreatic cancer and skin cancer, for monitoring the effectiveness of cancer, such as lung cancer, pancreatic cancer and skin cancer treatment, and for drug development.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 19, 2018
    Inventor: Lindsey Jane HUDSON
  • THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
    Publication number: 20160032006
    Abstract: The present disclosure provides methods and compositions for treatment, screening, diagnosis and prognosis of cancer, such as lung cancer, pancreatic cancer and skin cancer, for monitoring the effectiveness of cancer, such as lung cancer, pancreatic cancer and skin cancer treatment, and for drug development.
    Type: Application
    Filed: February 12, 2014
    Publication date: February 4, 2016
    Inventor: Lindsey Jane HUDSON
  • INACTIVE N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE PROTEIN 2 (NAALADL2) AS A THERAPEUTIC AND DIAGNOSTIC TARGET
    Publication number: 20160002351
    Abstract: The present invention provides methods and compositions for treatment, screening, diagnosis and prognosis of cancer, such as prostate cancer, bladder cancer, breast cancer, esophagus cancer, head and neck cancer, colorectal cancer, liver cancer, lung cancer, ovarian cancer, gastric cancer, uterus cancer and pancreatic cancer, for monitoring the effectiveness of cancer, such as prostate cancer, bladder cancer, breast cancer, esophagus cancer, head and neck cancer, colorectal cancer, liver cancer, lung cancer, ovarian cancer, gastric cancer, uterus cancer and pancreatic cancer treatment, and for drug development.
    Type: Application
    Filed: February 24, 2014
    Publication date: January 7, 2016
    Applicant: Oxford BioTherapeutics Limited
    Inventors: Lindsey Jane HUDSON, James Edward ACKROYD
  • EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA
    Publication number: 20110150877
    Abstract: The present invention provides a polypeptide (CCMP-1) of use in the diagnosis, screening, treatment and prophylaxis of carcinoma. Also provided are compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein.
    Type: Application
    Filed: November 24, 2009
    Publication date: June 23, 2011
    Inventors: Robert Simon Boyd, Graham Charles Fletcher, Lindsey Jane Hudson, Sonal Patel, Jonathan Alexander Terrett
  • Ephrin-B receptor protein involved in carcinoma
    Patent number: 7655426
    Abstract: The present invention provides a polypeptide (CCMP-1) of use in the diagnosis, screening, treatment and prophylaxis of carcinoma. Also provided are compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: February 2, 2010
    Assignee: Oxford Glycosciences (UK) Ltd
    Inventors: Robert Simon Boyd, Graham Charles Fletcher, Lindsey Jane Hudson, Sonal Patel, Jonathan Alexander Terrett